Tamsulosin palliates radiation-induced urethritis in patients with prostate cancer: Results of a pilot study

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 3, 1999, Pages 563-566

  Prosnitz, Robert G ^a   Schneider, Lindsey ^a   Manola, Judy ^a   Rocha, Sean ^a   Loffredo, Marian ^a   Lopes, Lynn ^b   D'Amico, Anthony V ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Complications; Conformal external beam radiation therapy; Flomax; Prostate cancer; Urethritis

Indexed keywords

TAMSULOSIN;

ARTICLE; BEAM THERAPY; CLINICAL ARTICLE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RADIATION INJURY; URETHRITIS;

HUMANS; MALE; PALLIATIVE CARE; PILOT PROJECTS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RECEPTORS, ADRENERGIC, ALPHA-1; SULFONAMIDES; URETHRITIS;

EID: 0032860831     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00246-1     Document Type: Article

References (17)

1. Hanks G.E. Conformal radiation in prostate cancer Reduced morbidity with hope of increased local control . Int J Radiat Oncol Biol Phys. 25:1993;377-378.
2. Wallner K., Roy J., Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. Int J Radiat Oncol Biol Phys. 14:1996;449-453.
3. Pollack A., Zagars G.K., Starkschall G., Childress C., Kopplin S., Boyer A.L., Rosen I.I. Conventional vs. conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity . Int J Radiat Oncol Biol Phys. 34:1996;555-564.
4. Physician's desk reference. 1998;Medical Economics, Montvale, NJ.
5. Bruno J.F., Whittaker J., Song J., et al. Molecular cloning and sequencing of a cDNA encoding the human alpha 1A adrenergic receptor. Biochem Biophys Res Commun. 179:1991;1485-1490.
6. Ramarao C.S., Denker J.M.K., Perez D.M., et al. Genomic organization and expression of the human alpha 1B-adrenergic receptor. J Biol Chem. 267:1992;21936-21945.
7. Perez D.M., Piascik M.T., Graham R.M. Solution-phase library screening for the identification of rare clones Isolation of an alpha 1D-adrenergic receptor cDNA . Mol Pharmacol. 40:1991;876-883.
8. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877.
9. Lepor H. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Urology. 51:1998;892-900.
10. Lepor H. Long-term evaluation of tamsulosin in benign prostatic hyperplasia Placebo-controlled, double-blind extension of phase III trial . Urology. 51:1998;901-906.
11. 1A-adrenoreceptor antagonist A meta-analysis of two randomized, placebo-controlled, multicenter studies in patients with benign prostatic obstruction (symptomatic BPH) . Eur Urol. 29:1996;155-167.
12. Schulman C.C., Cortvriend J., Jonas U., et al. Tamsulosin, the first prostate-selective alpha 1A-adrenoreceptor antagonist Analysis of a multinational, multicenter, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH) . Eur Urol. 29:1996;145-154.
13. Abrams P., Schulman C.C., Vaage S. Tamsulosin A selective alpha1C adrenoreceptor antagonist. A randomized, controlled trial in patients with benign prostatic "obstruction" (symptomatic BPH) . Br J Urol. 76:1995;325-336.
14. Beduschi M.C., Beduschi R., Oesterling J.E. Alpha-blockade therapy for benign prostatic hyperplasia From a nonselective to a more selective alpha1a-adrenergic antagonist . Urology. 51:1998;861-872.
15. 1A-adrenoreceptor in the human prostate. J Urol. 154:1995;2096-2099.
16. Cox D.R. Analysis of binary data. 1970;Methuen, London.
17. Neter J., Wasserman W., Kutner M. Simultaneous inferences and other topics in regression analysis-1. Neter J., Wasserman W., Kutner M. Applied linear regression models. 1st ed. 1983;150-153 Richard D. Irwin, Inc, Homewood, IL.